Suppr超能文献

通过鼻黏膜在外周调节性T细胞诱导中的早期事件。

Early events in peripheral regulatory T cell induction via the nasal mucosa.

作者信息

Unger Wendy W J, Hauet-Broere Femke, Jansen Wendy, van Berkel Lisette A, Kraal Georg, Samsom Janneke N

机构信息

Department of Molecular Cell Biology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.

出版信息

J Immunol. 2003 Nov 1;171(9):4592-603. doi: 10.4049/jimmunol.171.9.4592.

Abstract

Nasal application of soluble Ags leads to Ag-specific suppression of systemic immune responses. This tolerance can be transferred to naive mice by CD4(+) regulatory T cells (T(R) cells) from the spleen, but little is known about the induction of mucosal T(R) cells in vivo. To investigate the induction of T(R) cells in the nose-draining cervical lymph node (CLN), CD4(+) T cells from DO11.10 OVA TCR transgenic mice were transferred to BALB/c recipients. Within 48 h after nasal OVA application, CD4(+) DO11.10 T cells in CLN, but not in the peripheral lymph node, had divided. Similarly, nonmucosal (i.m.) OVA application also induced CD4(+) DO11.10 T cells to proliferate in the draining inguinal lymph node (ILN), yet more vigorously and with different kinetics than the CD4(+) DO11.10 T cells in CLN. Functional analysis revealed that only proliferating CD4(+) DO11.10 T cells from CLN, and not ILN, could transfer tolerance to naive recipients. CD4(+) DO11.10 T cells from CLN were phenotypically similar to CD4(+) DO11.10 T cells from ILN, however, in CLN a higher percentage of CD25(+) proliferating CD4(+) DO11.10 T cells were detected compared with ILN. CD25 is not a discriminative marker for mucosal T(R) cells because both CD25(+) and CD25(-) CD4(+) DO11.10 T cells from the CLN could suppress delayed type hypersensitivity responses in adoptive transfer. These findings demonstrate that although striking similarities exist between the differentiation of T(R) and effector T cells, this does not include their function. We are the first to demonstrate that functional T(R) cells, which reside within both CD25(+) and CD25(-) subsets, can be isolated from CLN as early as 3 days after nasal OVA application.

摘要

鼻腔应用可溶性抗原可导致抗原特异性抑制全身免疫反应。这种耐受性可通过脾脏中的CD4(+)调节性T细胞(T(R)细胞)传递给未致敏小鼠,但关于体内黏膜T(R)细胞的诱导知之甚少。为了研究引流鼻的颈部淋巴结(CLN)中T(R)细胞的诱导情况,将来自DO11.10 OVA TCR转基因小鼠的CD4(+) T细胞转移至BALB/c受体小鼠。鼻腔应用OVA后48小时内,CLN中的CD4(+) DO11.10 T细胞发生了分裂,但外周淋巴结中的未分裂。同样,非黏膜(肌肉注射)应用OVA也诱导CD4(+) DO11.10 T细胞在引流的腹股沟淋巴结(ILN)中增殖,但其增殖比CLN中的CD4(+) DO11.10 T细胞更强烈且动力学不同。功能分析显示,只有CLN中增殖的CD4(+) DO11.10 T细胞,而非ILN中的,能够将耐受性传递给未致敏受体。CLN中的CD4(+) DO11.10 T细胞在表型上与ILN中的CD4(+) DO11.10 T细胞相似,然而,与ILN相比,CLN中检测到更高比例的CD25(+)增殖CD4(+) DO11.10 T细胞。CD25不是黏膜T(R)细胞的鉴别标志物,因为来自CLN的CD25(+)和CD25(-) CD4(+) DO11.10 T细胞在过继转移中均能抑制迟发型超敏反应。这些发现表明,尽管T(R)细胞和效应T细胞的分化存在显著相似性,但这并不包括它们的功能。我们首次证明,早在鼻腔应用OVA后3天,就可从CLN中分离出存在于CD25(+)和CD25(-)亚群中的功能性T(R)细胞。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验